Compared with subjects in the lowest tertile of net acid excretion, those in the middle and highest tertiles had a 3.0 times and 9.9 times increased risk.
Researchers also discover that adherence to the diet is associated with slower eGFR decline.
Increasing age and receipt of a deceased-donor kidney were among risk factors for death from infection.
Decreasing TSAT and higher ESA doses are associated with increasing platelet counts.
Folic acid treatment significantly improved hemoglobin levels and decreased epoetin alfa use.
Declines in serum phosphorus over time may improve survival.
Patients whose statins were held in the 24 hours before cardiac surgery had higher levels of kidney injury biomarkers.
Greater proteinuria also associated with increased odds of masked and sustained hypertension.
Worsening or resistant hyperphosphatemia may be an under-appreciated consequence of secondary hyperparathyroidism.
Atorvastatin did not reduce the risk of a combined endpoint of cardiovascular death, MI, and stroke.
The effect may be mediated by an acute reduction in sympathetic nervous system activity.
Calcium-based and non-calcium-based binder use were associated with similar death risks.
Elemental iron requirement was reduced by half in patients receiving ferric citrate versus an active control.
Study demonstrated six- and 12-month survival rates of 58% and 49%, respectively.
Levels declined significantly from 7.2 to 5.0 mg/dL, data show.
The 5-year disease-free and cancer-specific survival rates were 94.7% and 100%, respectively.
In a small study, the treatment was associated with a 4-fold increase in average ejaculation time.
Study shows it can provide durable oncologic control with a low risk of tumor recurrence.
Researchers observe benefit in prostate cancer patients with 2 or more adverse pathologic features.
Pelvic lymph node dissection in high-risk patients is 2.5 times more likely in those undergoing open rather than robotic-assisted surgery.
Men with non-palpable tumors had a 46% lower risk of positive surgical margins.
Parenteral testosterone undecanoate over 5 years found to decrease waist circumference and improve components of metabolic syndrome.
Alpha blockers and 5-alpha reductase inhibitors increase the risk of ejaculatory dysfunction, a systematic review and meta-analysis shows.
Risk is not eliminated if patients have risk factors for chronic kidney disease, such as hypertension and diabetes.
Patients are more than 9 times more likely to die from causes other than PCa, a new study shows.
It is associated with a 34.7% decrease in biochemical recurrence after radical prostatectomy versus patients with blood type A.
Diabetes also found to increase cancer-specific mortality in patients with clear cell renal cell carcinoma.
Patients diagnosed with the cancer in 2011 were 2.5 times more likely to be managed expectantly than those diagnosed in 2004.
ACE inhibitors and angiotensin receptor blockers were shown to prolong median overall survival by nine months.
The risk of PCa death or distant metastases is 61% lower in men with blood group AB compared with those who have blood group O.